Year | PCOS | Endometriosis | Uterine fibroids | Cervical cancer | Ovarian cancer | Uterine cancer |
---|---|---|---|---|---|---|
1990 | Â | Â | Â | Â | Â | Â |
Incidence (× 105, 95% UI) | 14.76(10.58–20.45) | 33.30(23.09–45.07) | 60.10(43.90-80.11) | 4.10(3.83–4.39) | 1.59(14.57-17,41) | 1.91(1.75–2.012) |
Prevalence (× 105, 95% UI) | 366.51(262.28-506.04) | 198.70(135.86–276.90) | 656.95(500.22-855.58) | 18.26(17.27–19.29) | 6.29(5.72–6.93) | 13.33(12.26–13.99) |
Mortality (95% UI) | - | 24.83(13.90-48.88) | 1125.85(765.03-1456.02) | 211483.79(195724.27-229841.01) | 100584.11(92970.81-109087.03) | 54848.89(48803.56-59116.13) |
DALYs (× 105, 95% UI) | 3.24(1.44–6.8) | 18.29(10.33–2.86) | 0.81(0.57–1.12) | 74.16(68.41–80.71) | 29.09(26.62–31.99) | 15.01(12.98–16.38) |
ASIR (1/100,000, 95% UI) | 49.45(35.57–68.45) | 119.65(83.51-160.46) | 234.36(171.06-309.92) | 18.11(16.94–19.40) | 7.22(6.65–7.87) | 8.87(8.12–9.35) |
ASPR (1/100,000, 95% UI) | 1372.77(984.64-1891.60) | 757.10(515.25-1046.13) | 2799.88(2133.46-3650.54) | 78.15(73.89–82.51) | 27.62(25.26–30.26) | 61.17(56.35–64.14) |
ASMR (1/100,000, 95% UI) | - | 0.00(0.00–0.00) | 0.05(0.04–0.07) | 9.68(8.97–10.51) | 4.73(4.38–5.12) | 2.60(2.32–2.80) |
ASDR (1/100,000, 95% UI) | 12.08(5.38–25.21) | 69.60(39.69-109.37) | 3.48(2.46–4.77) | 330.11(304.67–359.10) | 132.48(121.34-145.63) | 69.17(59.85–75.30) |
2021 | Â | Â | Â | Â | Â | Â |
Incidence (× 105, 95% UI) | 23.02(16.56–31.67) | 34.47(24.36–46.12) | 101.00(73.50-132.86) | 6.67(6.13–7.26) | 2.99(2.71–3.25) | 4.74(4.30–5.14) |
Prevalence (× 105, 95% UI) | 694.73(495.31-957.24) | 222.75(155.17-304.14) | 1195.45(912.28-1549.44) | 33.85(31.08–36.97) | 12.22(11.02–13.32) | 34.52(31.65–37.25) |
Mortality (95% UI) | - | 54.17(21.51-121.92) | 2077.75(1225.41-2574.28) | 296667.24(272058.62-321905.72) | 185608.68(167961.98-201012.67) | 97672.08(86515.79-108061.54) |
DALYs (× 105, 95% UI) | 6.08(2.73–12.69) | 20.49(11.95–31.34) | 1.43(1.02–1.93) | 99.12(90.53-107.98) | 51.63(46.92–56.08) | 25.63(22.91–28.46) |
ASIR (1/100,000, 95% UI) | 63.26(45.41–87.28) | 88.52(62.53-119.55) | 250.93(183.44-330.94) | 15.32(14.08–16.68) | 6.71(6.07–7.28) | 10.36(9.42–11.24) |
ASPR (1/100,000, 95% UI) | 1757.83(1253.36-2421.26) | 556.98(388.85-764.05) | 2841.07(2164.43-3682.27) | 79.30(72.81–86.58) | 28.08(25.26–30.64) | 75.73(69.37–81.78) |
ASMR (1/100,000, 95% UI) | - | 0.00(0.00–0.00) | 0.05(0.03–0.06) | 6.62(6.07–7.18) | 4.06(3.67–4.40) | 2.11(1.87–2.34) |
ASDR (1/100,000, 95% UI) | 15.40(6.91–32.13) | 51.27(29.87–78.43) | 3.39(2.43–4.59) | 226.28(206.51-246.86) | 115.15(104.58-125.21) | 56.15(50.07–62.37) |
1990–2021 |  |  |  |  |  |  |
ASIR (EAPC, 95% CI) | 0.77(0.75–0.79) | -1.00(-1.05–0.95) | 0.24(0.23–0.25) | -0.54(-0.64–0.44) | -0.38(-0.43–0.32) | 0.54(0.50–0.58) |
ASPR (EAPC, 95% CI) | 0.74(0.70–0.77) | -1.02(-1.07–0.97) | 0.04(0.03–0.06) | 0.12(0.03–0.21) | -0.07(-0.13-0.00) | 0.77(0.72–0.82) |
ASMR (EAPC, 95% CI) | - | 1.27(1.03–1.51) | 0.06(-0.07-0.20) | -1.27(-1.36–1.18) | -0.62(-0.68–0.57) | -0.78(-0.85–0.70) |
ASDR (EAPC, 95% CI) | 0.72(0.68–0.76) | -1.01(-1.06–0.96) | 0.05(-0.01-0.11) | -1.27(-1.36–1.17) | -0.59(-0.64–0.54) | -0.78(-0.85–0.71) |